AI assistant
Sarepta Therapeutics, Inc. — Director's Dealing 2012
Nov 29, 2012
31721_dirs_2012-11-29_abf43e26-e255-4800-8c75-288385ecf4d3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2012-11-27
Reporting Person: CHASE ANTHONY R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-27 | Common Stock | S | 1100 | $29.0368 | Disposed | 26144 | Direct |
| 2012-11-28 | Common Stock | S | 1600 | $28.1681 | Disposed | 24544 | Direct |
| 2012-11-28 | Common Stock | S | 5700 | $29.7002 | Disposed | 18844 | Direct |
| 2012-11-28 | Common Stock | S | 1600 | $30.2056 | Disposed | 17244 | Direct |
Footnotes
F1: This transaction was executed in multiple trades in prices ranging from $29.00 to $29.11, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F2: This transaction was executed in multiple trades in prices ranging from $27.79 to $28.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3: This transaction was executed in multiple trades in prices ranging from $29.35 to $29.95, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4: This transaction was executed in multiple trades in prices ranging from $30.00 to $30.60, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.